| Literature DB >> 31434898 |
Ruting Xu1, Tianxiao Xu1, Mingcheng Yang1, Tianpeng Cao1, Saihu Liao2.
Abstract
The past few years have witnessed a fast-growing research interest on the study of sulfonyl fluorides as reactive probes in chemical biology and molecular pharmacology, which raises an urgent need for the development of effective synthetic methods to expand the toolkit. Herein, we present the invention of a facile and general approach for the synthesis of aliphatic sulfonyl fluorides via visible-light-mediated decarboxylative fluorosulfonylethylation. The method is based on abundant carboxylic acid feed stock, applicable to various alkyl carboxylic acids including primary, secondary, and tertiary acids, and is also suitable for the modification of natural products like amino acids, peptides, as well as drugs, forging a rapid, metal-free approach to build sulfonyl fluoride compound libraries of considerable structural diversity. Further diversification of the SO2F-containing products is also demonstrated, which allows for access to a range of pharmaceutically important motifs such as sultam, sulfonate, and sulfonamide.Entities:
Year: 2019 PMID: 31434898 PMCID: PMC6704106 DOI: 10.1038/s41467-019-11805-6
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Aliphatic RSO2F inhibitors and the synthetic strategies. a Selected examples of aliphatic sulfonyl fluoride inhibitors. b Conventional synthetic routes to aliphatic sulfonyl fluorides. c Synthesis of aliphatic sulfonyl fluorides from carboxylic acids via visible-light-mediated decarboxylation (this work)
Reaction optimization (Reaction conditions: 0.05 mmol scale, VSF (2 eq), photocatalyst (5 mol%), in MeCN (0.5 mL) at room temperature, under the irradiation of 18 W × 2 blue LED bulbs. Left entries: with DIPEA (2 eq) as the reductant. Right entries: with Eosin Y-Na2 (5 mol%) as the catalyst)
|
| |||||
|---|---|---|---|---|---|
| Entry | Photocatalyst | Yielda | Entry | Reductant | Yielda |
| 1 | Ir(ppy)3 | 29% | 10 | TEA | <2% |
| 2 | [Ru(bpy)3]Cl2·6H2O | 24% | 11 | DMA | N.P. |
| 3 | Eosin Y | 35% | 12 | TMEDA | <2% |
| 4 | Fluorescein | 26% | 13 | PMDETA | N.P. |
| 5 | Rhodamine B | 17% | 14 | HE | 89% |
| 6 | Rhodamine 6G | 26% | 15 | HE/DIPEA 2:1 | 73% |
| 7 | Isatin | 32% | 16 | HE/TEA 2:1 | 29% |
| 8b | Eosin Y | 38% | 17c | HE | 69% |
| 9 | Eosin Y-Na2 | 37% | 18d | HE | N.P. |
DMA N,Nʹ-dimethylaniline, TMEDA N,N,Nʹ,Nʹ-tetramethylethanediamine, PMDETA N,N,Nʹ,Nʺ,Nʺ-pentamethyldiethylenetriamine
aDetermined by 19F NMR with PhCF3 as an internal standard or by GC-MS analysis
bEosin Y (10 mol%), VSF (5 eq), in DCM, green LED, 18 h
cWith 1 eq of VSF
dIn dark, N.P. = no product was observed
Fig. 2Substrate scope. Reactions were performed on a 0.2 mmol scale, and all yields represent isolated yields. Substrates for 33, 34 and 37 are unnaturally occurring amino acids
Fig. 3Reaction practicability and diversification of products. a Scale-up, one-pot reaction. b Modification of peptide. c Diversification of products through SuFEx chemistry